Found: 58
Select item for more details and to access through your institution.
A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.897951
- By:
- Publication type:
- Article
Association of HLA-G 3′UTR Polymorphisms with Response to First-Line FOLFIRI Treatment in Metastatic Colorectal Cancer.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 12, p. 2737, doi. 10.3390/pharmaceutics14122737
- By:
- Publication type:
- Article
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3303, doi. 10.3390/ijms24043303
- By:
- Publication type:
- Article
CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 17, p. 6350, doi. 10.3390/ijms21176350
- By:
- Publication type:
- Article
Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients' Management and Therapy Outcomes.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 21, p. 5498, doi. 10.3390/ijms20215498
- By:
- Publication type:
- Article
rs4143815-PDL1, a New Potential Immunogenetic Biomarker of Biochemical Recurrence in Locally Advanced Prostate Cancer after Radiotherapy.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 9, p. 2082, doi. 10.3390/ijms20092082
- By:
- Publication type:
- Article
Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS).
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 5, p. 1510, doi. 10.3390/ijms19051510
- By:
- Publication type:
- Article
Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 7, p. 1522, doi. 10.3390/ijms18071522
- By:
- Publication type:
- Article
HLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 7, p. 1366, doi. 10.3390/ijms18071366
- By:
- Publication type:
- Article
Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 9, p. 1482, doi. 10.3390/ijms17091482
- By:
- Publication type:
- Article
The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity.
- Published in:
- Human Genomics, 2023, v. 17, n. 1, p. 1, doi. 10.1186/s40246-023-00546-9
- By:
- Publication type:
- Article
Sex Disparities in Efficacy in COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2021, v. 9, n. 8, p. 825, doi. 10.3390/vaccines9080825
- By:
- Publication type:
- Article
Decision criteria for rational selection of homogeneous genotyping platforms for pharmacogenomics testing in clinical diagnostics.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2010, v. 48, n. 4, p. 447, doi. 10.1515/CCLM.2010.112
- By:
- Publication type:
- Article
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2023, v. 31, n. 2, p. 267, doi. 10.1007/s40199-023-00465-z
- By:
- Publication type:
- Article
SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.778781
- By:
- Publication type:
- Article
Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients.
- Published in:
- AAPS Journal, 2020, v. 22, n. 3, p. 1, doi. 10.1208/s12248-020-0429-4
- By:
- Publication type:
- Article
HLA-G 3’UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0144000
- By:
- Publication type:
- Article
Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0084940
- By:
- Publication type:
- Article
Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00897
- By:
- Publication type:
- Article
Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib.
- Published in:
- Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2020.00036
- By:
- Publication type:
- Article
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 3, p. 1089, doi. 10.1111/bcp.15551
- By:
- Publication type:
- Article
Predictive and Prognostic Value of Oncogene Mutations and Microsatellite Instability in Locally-Advanced Rectal Cancer Treated with Neoadjuvant Radiation-Based Therapy: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1469, doi. 10.3390/cancers15051469
- By:
- Publication type:
- Article
IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1705, doi. 10.3390/cancers13071705
- By:
- Publication type:
- Article
Genetic Variants of the TERT Gene, Telomere Length, and Circulating TERT as Prognostic Markers in Rectal Cancer Patients.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3115, doi. 10.3390/cancers12113115
- By:
- Publication type:
- Article
UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population.
- Published in:
- Liver International, 2017, v. 37, n. 9, p. 1345, doi. 10.1111/liv.13411
- By:
- Publication type:
- Article
Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-49477-3
- By:
- Publication type:
- Article
Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 3, p. 652, doi. 10.1002/cpt.2960
- By:
- Publication type:
- Article
Machine Learning Application in a Phase I Clinical Trial Allows for the Identification of Clinical‐Biomolecular Markers Significantly Associated With Toxicity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 3, p. 686, doi. 10.1002/cpt.2511
- By:
- Publication type:
- Article
Educating the Next Generation of Pharmacogenomics Experts: Global Educational Needs and Concepts.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 2, p. 313, doi. 10.1002/cpt.1471
- By:
- Publication type:
- Article
Clinical Implementation of Rare and Novel DPYD Variants for Personalizing Fluoropyrimidine Treatment: Challenges and Opportunities.
- Published in:
- International Journal of Biological Sciences, 2024, v. 21, n. 10, p. 3742, doi. 10.7150/ijbs.97686
- By:
- Publication type:
- Article
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 3, p. 361, doi. 10.1007/s00280-020-04122-z
- By:
- Publication type:
- Article
A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy.
- Published in:
- Frontiers in Pharmacology, 2018, p. N.PAG, doi. 10.3389/fphar.2018.01101
- By:
- Publication type:
- Article
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients.
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00367
- By:
- Publication type:
- Article
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines.
- Published in:
- International Journal of Cancer, 2015, v. 137, n. 12, p. 2971, doi. 10.1002/ijc.29654
- By:
- Publication type:
- Article
Correction: Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Correction: Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 4, p. 1, doi. 10.1038/s41419-022-04741-9
- By:
- Publication type:
- Article
BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress.
- Published in:
- Cell Death & Disease, 2016, v. 7, n. 12, p. e2526, doi. 10.1038/cddis.2016.448
- By:
- Publication type:
- Article
BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress.
- Published in:
- Cell Death & Disease, 2016, v. 7, n. 9, p. e2374, doi. 10.1038/cddis.2016.278
- By:
- Publication type:
- Article
Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A pharmacogenetic survey of androgen receptor (CAG)n and (GGN)n polymorphisms in patients experiencing long term side effects after finasteride discontinuation.
- Published in:
- International Journal of Biological Markers, 2014, v. 29, n. 4, p. e310, doi. 10.5301/jbm.5000095
- By:
- Publication type:
- Article
Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC).
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 10, p. 1186, doi. 10.3390/cells8101186
- By:
- Publication type:
- Article
New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 6, p. 584, doi. 10.3390/cells8060584
- By:
- Publication type:
- Article
Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00712
- By:
- Publication type:
- Article
Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries.
- Published in:
- PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0268534
- By:
- Publication type:
- Article
The challenge of molecular selection in liver-limited metastatic colorectal cancer for surgical resection: a systematic review and meta-analysis in the context of current and future approaches.
- Published in:
- Oncology Research, 2024, v. 32, n. 9, p. 1407, doi. 10.32604/or.2024.049181
- By:
- Publication type:
- Article
A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
- Published in:
- Oncology Research, 2020, v. 28, n. 9, p. 847, doi. 10.3727/096504021X16232280278813
- By:
- Publication type:
- Article